PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.83+0.06 (+2.17%)
Close on Oct 19, 2026Market cap $2.26MP/E –Yield –
PMGC free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
PMGC's free cash flow for the twelve months ending Sep 30, 2026 was -$10.02M. For fiscal 2025 it was -$6.38M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.38M | – |
| FY2024 | Dec 31, 2024 | -$5.50M | – |
| FY2023 | Dec 31, 2023 | -$4.57M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.62M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.96M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.34M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$381.68K | – |
| Q2 FY2024 | Jun 30, 2024 | -$780.69K | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.33M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.39M | – |
| Q3 FY2023 | Sep 30, 2023 | -$514.40K | – |
| Q2 FY2023 | Jun 30, 2023 | -$768.76K | – |
| Q1 FY2023 | Mar 31, 2023 | -$896.70K | – |
See a number that looks wrong?